Soleus Capital Management’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $695K | Buy |
+100,000
| New | +$695K | 0.05% | 88 |
|
|
2024
Q4 | – | Sell |
-78,315
| Closed | -$1.77M | – | 86 |
|
|
2024
Q3 | $1.77M | Buy |
78,315
+54,815
| +233% | +$1.24M | 0.14% | 80 |
|
|
2024
Q2 | $476K | Sell |
23,500
-129,500
| -85% | -$2.62M | 0.04% | 89 |
|
|
2024
Q1 | $3.81M | Buy |
153,000
+58,000
| +61% | +$1.44M | 0.28% | 67 |
|
|
2023
Q4 | $1.72M | Sell |
95,000
-296,800
| -76% | -$5.37M | 0.19% | 56 |
|
|
2023
Q3 | $7.87M | Sell |
391,800
-20,000
| -5% | -$402K | 0.73% | 38 |
|
|
2023
Q2 | $10.5M | Hold |
411,800
| – | – | 1.17% | 26 |
|
|
2023
Q1 | $8.76M | Buy |
411,800
+153,400
| +59% | +$3.26M | 0.91% | 30 |
|
|
2022
Q4 | $7.65M | Buy |
+258,400
| New | +$7.65M | 1.1% | 29 |
|
|
2022
Q1 | – | Sell |
-10,250
| Closed | -$624K | – | 69 |
|
|
2021
Q4 | $624K | Buy |
+10,250
| New | +$624K | 0.06% | 61 |
|